Endurance Athletes Are at Increased Risk for Early Acute Mountain Sickness at 3450 m

التفاصيل البيبلوغرافية
العنوان: Endurance Athletes Are at Increased Risk for Early Acute Mountain Sickness at 3450 m
المؤلفون: Peter Schmidt, Larissa Schäfer, Quirin Zangl, Lisa M. Schiefer, Bernhard Reich, Barbara Mayr, Arnulf Hartl, Marc M. Berger, Josef Niebauer, Franciscus Inama, Gunnar Treff, Franziska Macholz, Mahdi Sareban, Peter Bärtsch
المصدر: Medicine & Science in Sports & Exercise. 52:1109-1115
بيانات النشر: Ovid Technologies (Wolters Kluwer Health), 2019.
سنة النشر: 2019
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Acclimatization, Physical Therapy, Sports Therapy and Rehabilitation, Hypoxic ventilatory response, Altitude Sickness, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Altitude, Heart Rate, Parasympathetic Nervous System, Internal medicine, Heart rate, medicine, Humans, Heart rate variability, Orthopedics and Sports Medicine, Prospective Studies, biology, Athletes, business.industry, VO2 max, 030229 sport sciences, biology.organism_classification, Oxygen, Increased risk, Acute Disease, Basal metabolic rate, Physical Endurance, Cardiology, Basal Metabolism, Pulmonary Ventilation, business, Physical Conditioning, Human
الوصف: INTRODUCTION Acute mountain sickness (AMS) may develop in nonacclimatized individuals after exposure to altitudes ≥2500 m. Anecdotal reports suggest that endurance-trained (ET) athletes with a high maximal oxygen uptake (V˙O2max) may be at increased risk for AMS. Possible underlying mechanisms include a training-induced increase in resting parasympathetic activity, higher resting metabolic rate (RMR), and lower hypoxic ventilatory response (HVR). METHODS In 38 healthy, nonacclimatized men (19 ET and 19 untrained controls [UT], V˙O2max 66 ± 6 mL·min·kg vs 45 ± 7 mL·min·kg; P < 0.001) peripheral oxygen saturation (SpO2), heart rate variability, RMR, and poikilocapnic HVR were assessed at 424 m and during 48 h at 3450 m after passive ascent by train (~2 h). Acute mountain sickness was evaluated by AMS cerebral (AMS-C) score. RESULTS On day 1 at altitude, ET presented with a higher AMS incidence (42% vs 11%; P < 0.05) and severity (AMS-C score: ET, 0.48 ± 0.5 vs UT, 0.21 ± 0.2; P = 0.03), but no group difference was found on days 2 and 3. SpO2 decreased upon arrival at altitude (ET: 82% ± 6% vs UT: 83% ± 4%; ptime
تدمد: 1530-0315
0195-9131
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faf5286bd1147d2992eede13b2bdcc95Test
https://doi.org/10.1249/mss.0000000000002232Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....faf5286bd1147d2992eede13b2bdcc95
قاعدة البيانات: OpenAIRE